vs
Astrana Health, Inc.（ASTH）与简柏特（G）财务数据对比。点击上方公司名可切换其他公司
简柏特的季度营收约是Astrana Health, Inc.的1.4倍（$1.3B vs $950.5M）。简柏特净利率更高（10.8% vs 0.7%，领先10.2%）。Astrana Health, Inc.同比增速更快（42.9% vs 5.6%）。简柏特自由现金流更多（$269.0M vs $-6.0M）。过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 8.0%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
简柏特是全球领先的信息技术服务、咨询及外包提供商，总部位于美国纽约，最初成立于印度古尔冈，法定注册地为百慕大。集团现有员工超12.5万名，服务覆盖全球30多个国家，于纽交所上市，2023年总营收达44.8亿美元。
ASTH vs G — 直观对比
营收规模更大
G
是对方的1.4倍
$950.5M
营收增速更快
ASTH
高出37.2%
5.6%
净利率更高
G
高出10.2%
0.7%
自由现金流更多
G
多$275.0M
$-6.0M
两年增速更快
ASTH
近两年复合增速
8.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $1.3B |
| 净利润 | $6.6M | $143.1M |
| 毛利率 | — | 36.6% |
| 营业利润率 | 1.9% | 14.8% |
| 净利率 | 0.7% | 10.8% |
| 营收同比 | 42.9% | 5.6% |
| 净利润同比 | 184.4% | 0.8% |
| 每股收益（稀释后） | $0.12 | $0.82 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHG
| Q4 25 | $950.5M | $1.3B | ||
| Q3 25 | $956.0M | $1.3B | ||
| Q2 25 | $654.8M | $1.3B | ||
| Q1 25 | $620.4M | $1.2B | ||
| Q4 24 | $665.2M | $1.2B | ||
| Q3 24 | $478.7M | $1.2B | ||
| Q2 24 | $486.3M | $1.2B | ||
| Q1 24 | $404.4M | $1.1B |
净利润ASTHG
| Q4 25 | $6.6M | $143.1M | ||
| Q3 25 | $373.0K | $145.8M | ||
| Q2 25 | $9.4M | $132.7M | ||
| Q1 25 | $6.7M | $130.9M | ||
| Q4 24 | $-7.8M | $141.9M | ||
| Q3 24 | $16.1M | $132.8M | ||
| Q2 24 | $19.2M | $122.0M | ||
| Q1 24 | $14.8M | $116.9M |
毛利率ASTHG
| Q4 25 | — | 36.6% | ||
| Q3 25 | — | 36.4% | ||
| Q2 25 | — | 35.9% | ||
| Q1 25 | — | 35.3% | ||
| Q4 24 | — | 35.7% | ||
| Q3 24 | — | 35.6% | ||
| Q2 24 | — | 35.4% | ||
| Q1 24 | — | 35.0% |
营业利润率ASTHG
| Q4 25 | 1.9% | 14.8% | ||
| Q3 25 | 2.0% | 14.8% | ||
| Q2 25 | 3.1% | 14.3% | ||
| Q1 25 | 3.3% | 15.1% | ||
| Q4 24 | 0.1% | 15.2% | ||
| Q3 24 | 5.9% | 15.0% | ||
| Q2 24 | 6.2% | 14.5% | ||
| Q1 24 | 7.5% | 14.1% |
净利率ASTHG
| Q4 25 | 0.7% | 10.8% | ||
| Q3 25 | 0.0% | 11.3% | ||
| Q2 25 | 1.4% | 10.6% | ||
| Q1 25 | 1.1% | 10.8% | ||
| Q4 24 | -1.2% | 11.4% | ||
| Q3 24 | 3.4% | 11.0% | ||
| Q2 24 | 3.9% | 10.4% | ||
| Q1 24 | 3.7% | 10.3% |
每股收益（稀释后）ASTHG
| Q4 25 | $0.12 | $0.82 | ||
| Q3 25 | $0.01 | $0.83 | ||
| Q2 25 | $0.19 | $0.75 | ||
| Q1 25 | $0.14 | $0.73 | ||
| Q4 24 | $-0.14 | $0.80 | ||
| Q3 24 | $0.33 | $0.74 | ||
| Q2 24 | $0.40 | $0.67 | ||
| Q1 24 | $0.31 | $0.64 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $1.2B |
| 总债务越低越好 | — | $1.5B |
| 股东权益账面价值 | $779.3M | $2.5B |
| 总资产 | $2.2B | $5.8B |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资ASTHG
| Q4 25 | $429.5M | $1.2B | ||
| Q3 25 | $463.4M | $740.8M | ||
| Q2 25 | $342.1M | $663.3M | ||
| Q1 25 | $260.9M | $561.6M | ||
| Q4 24 | $290.8M | $671.6M | ||
| Q3 24 | $350.3M | $1.0B | ||
| Q2 24 | $327.7M | $914.2M | ||
| Q1 24 | $337.3M | $478.4M |
总债务ASTHG
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | — | $1.6B | ||
| Q1 24 | — | $1.2B |
股东权益ASTHG
| Q4 25 | $779.3M | $2.5B | ||
| Q3 25 | $775.5M | $2.5B | ||
| Q2 25 | $765.5M | $2.6B | ||
| Q1 25 | $745.4M | $2.5B | ||
| Q4 24 | $712.7M | $2.4B | ||
| Q3 24 | $704.6M | $2.4B | ||
| Q2 24 | $678.9M | $2.3B | ||
| Q1 24 | $653.5M | $2.3B |
总资产ASTHG
| Q4 25 | $2.2B | $5.8B | ||
| Q3 25 | $2.2B | $5.4B | ||
| Q2 25 | $1.4B | $5.3B | ||
| Q1 25 | $1.3B | $4.9B | ||
| Q4 24 | $1.4B | $5.0B | ||
| Q3 24 | $1.3B | $5.3B | ||
| Q2 24 | $1.3B | $5.2B | ||
| Q1 24 | $1.2B | $4.7B |
负债/权益比ASTHG
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.47× | ||
| Q2 25 | — | 0.47× | ||
| Q1 25 | — | 0.50× | ||
| Q4 24 | — | 0.51× | ||
| Q3 24 | — | 0.68× | ||
| Q2 24 | — | 0.70× | ||
| Q1 24 | — | 0.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $286.7M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $269.0M |
| 自由现金流率自由现金流/营收 | -0.6% | 20.4% |
| 资本支出强度资本支出/营收 | 0.3% | 1.3% |
| 现金转化率经营现金流/净利润 | -0.44× | 2.00× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $734.7M |
8季度趋势，按日历期对齐
经营现金流ASTHG
| Q4 25 | $-2.9M | $286.7M | ||
| Q3 25 | $10.0M | $308.4M | ||
| Q2 25 | $90.9M | $177.4M | ||
| Q1 25 | $16.6M | $40.4M | ||
| Q4 24 | $-10.9M | $203.2M | ||
| Q3 24 | $34.0M | $228.5M | ||
| Q2 24 | $23.2M | $209.3M | ||
| Q1 24 | $6.0M | $-25.6M |
自由现金流ASTHG
| Q4 25 | $-6.0M | $269.0M | ||
| Q3 25 | $7.4M | $292.0M | ||
| Q2 25 | $89.5M | $155.1M | ||
| Q1 25 | $13.6M | $18.5M | ||
| Q4 24 | $-13.5M | $183.5M | ||
| Q3 24 | $31.7M | $208.7M | ||
| Q2 24 | $20.4M | $190.0M | ||
| Q1 24 | $5.6M | $-49.6M |
自由现金流率ASTHG
| Q4 25 | -0.6% | 20.4% | ||
| Q3 25 | 0.8% | 22.6% | ||
| Q2 25 | 13.7% | 12.4% | ||
| Q1 25 | 2.2% | 1.5% | ||
| Q4 24 | -2.0% | 14.7% | ||
| Q3 24 | 6.6% | 17.2% | ||
| Q2 24 | 4.2% | 16.2% | ||
| Q1 24 | 1.4% | -4.4% |
资本支出强度ASTHG
| Q4 25 | 0.3% | 1.3% | ||
| Q3 25 | 0.3% | 1.3% | ||
| Q2 25 | 0.2% | 1.8% | ||
| Q1 25 | 0.5% | 1.8% | ||
| Q4 24 | 0.4% | 1.6% | ||
| Q3 24 | 0.5% | 1.6% | ||
| Q2 24 | 0.6% | 1.6% | ||
| Q1 24 | 0.1% | 2.1% |
现金转化率ASTHG
| Q4 25 | -0.44× | 2.00× | ||
| Q3 25 | 26.69× | 2.11× | ||
| Q2 25 | 9.65× | 1.34× | ||
| Q1 25 | 2.48× | 0.31× | ||
| Q4 24 | — | 1.43× | ||
| Q3 24 | 2.11× | 1.72× | ||
| Q2 24 | 1.21× | 1.72× | ||
| Q1 24 | 0.40× | -0.22× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
G
| High Tech And Manufacturing | $525.3M | 40% |
| Consumer And Healthcare | $445.8M | 34% |
| Financial Services | $348.2M | 26% |
